| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.57B | $4.60B | $5.11B |
| YoY Revenue Growth % | -0.6% | -10.0% | — |
| Gross Profit | $782.2M | $834.2M | — |
| Gross Margin % | 17.1% | 18.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$30.8M | $31.5M | $228.1M |
| Operating Margin % | -0.7% | 0.7% | 4.5% |
| Net Income (GAAP) | -$56.4M | -$8.6M | $145.7M |
| EBITDA (Normalized) | $10.4M | $111.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $87.0M | $204.9M | $365.1M |
| Capital Expenditures (CapEx) | $51.5M | $99.6M | — |
| Free Cash Flow (FCF) | $35.5M | $105.3M | $365.1M |
| FCF Margin % | 0.8% | 2.3% | 7.1% |
| Return on Invested Capital (ROIC %) | -3.4% | 3.2% | — |
| Cash & Short-Term Equivalents | $26.9M | $27.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $753.1M | $815.3M | — |